We are live on !
Find out more
John Paulson Paulson & Co
AUM
$2.58B
Turnover
30%
1-Year Est. Return
68.51%
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
This Fund
S&P 500
This Quarter Est. Return
-3.23%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$5.57B
AUM Growth
-$1.83B
(-25%)
Cap. Flow
-$1.38B
Cap. Flow % of AUM
Cap. Flow %
-24.83%
Top 10 Holdings %
Top 10 Hldgs %
64.19%
Holding
115
New
6
Increased
5
Reduced
20
Closed
62
Avg Time Held
Equity + Options
2.2
years
Top 10 Avg Time Held
Equity + Options
1.2
years
Top 20 Avg Time Held
Equity + Options
1.4
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
1.2
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$69M |
| 2 |
DISH
DISH Network Corp.
DISH
|
+$40.1M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$24M |
| 4 |
Sprint Corporation
S
|
+$19.5M |
| 5 |
EQT Corp
EQT
|
+$18.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$259M |
| 2 |
NXP Semiconductors
NXPI
|
+$133M |
| 3 |
AGN
Allergan plc
AGN
|
+$122M |
| 4 |
Anywhere Real Estate
HOUS
|
+$101M |
| 5 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$96.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.18% |
| 2 | Communication Services | 17.11% |
| 3 | Miscellaneous | 11.91% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Materials | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
SPDR Gold Trust
GLD
$135B
| $530M | 9.52% |
4,359,722
| – | – |
2013 Q2
17 quarters
|
|
|
SHPG
2
DELISTED
Shire pic
SHPG
| $483M | 8.67% |
3,153,400
-328,200
| -9% | -$51.4M |
2013 Q2
17 quarters
|
|
3
Viatris
VTRS
$21.7B
| $462M | 8.29% |
14,718,600
-1,215,000
| -8% | -$41.2M |
2013 Q2
17 quarters
|
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $447M | 8.02% |
2,180,292
-523,278
| -19% | -$122M |
2014 Q1
14 quarters
|
|
5
T-Mobile US
TMUS
$170B
| $321M | 5.76% |
5,200,000
-850,700
| -14% | -$53.3M |
2017 Q1
2 quarters
|
|
6
Bausch Health
BHC
$3.1B
| $299M | 5.36% |
20,839,035
-974,365
| -4% | -$14.7M |
2014 Q1
14 quarters
|
|
|
CACQ
7
DELISTED
Caesars Acquisition Company
CACQ
| $281M | 5.05% |
13,117,998
| – | – |
2013 Q4
15 quarters
|
|
|
DISH
8
DELISTED
DISH Network Corp.
DISH
| $254M | 4.55% |
4,676,700
+677,900
| +17% | +$40.1M |
2017 Q1
2 quarters
|
|
|
AABA
9
DELISTED
Altaba Inc
AABA
| $252M | 4.52% |
3,799,200
+1,124,200
| +42% | +$69M |
2017 Q2
1 quarter
|
|
|
TWX
10
DELISTED
Time Warner Inc
TWX
| $249M | 4.46% |
2,426,155
-560,300
| -19% | -$56.8M |
2016 Q4
3 quarters
|
|
|
MNK
11
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $248M | 4.45% |
6,626,672
-264,700
| -4% | -$10.5M |
2013 Q3
16 quarters
|
|
12
Vistra
VST
$41.7B
| $216M | 3.87% |
11,530,556
| – | – |
2017 Q2
1 quarter
|
|
13
DELISTED
Caesars Entertainment Corporation
CZR
| $192M | 3.46% |
14,417,900
| – | – |
2013 Q2
17 quarters
|
|
14
AngloGold Ashanti
AU
$43.5B
| $119M | 2.13% |
12,782,400
| – | – |
2013 Q2
17 quarters
|
|
15
TIM SA
TIMB
$8.63B
| $101M | 1.82% |
5,550,600
| – | – |
2014 Q2
13 quarters
|
|
16
NovaGold Resources
NG
$2.75B
| $90.6M | 1.63% |
21,992,896
| – | – |
2013 Q2
17 quarters
|
|
17
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $82.9M | 1.49% |
6,263,526
| – | – |
2013 Q2
17 quarters
|
|
|
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $70.7M | 1.27% |
5,578,850
+643,350
| +13% | +$8.18M |
2017 Q2
1 quarter
|
|
|
SGYP
19
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $69.8M | 1.25% |
24,062,368
-26,287
| -0.1% | -$89.7K |
2015 Q1
10 quarters
|
|
20
International Seaways
INSW
$5.25B
| $68.1M | 1.22% |
3,456,773
| – | – |
2016 Q4
3 quarters
|
|
|
ENDP
21
DELISTED
Endo International plc
ENDP
| $61.4M | 1.1% |
7,174,490
| – | – |
2015 Q3
8 quarters
|
|
22
Brookdale Senior Living
BKD
$2.55B
| $52.9M | 0.95% |
4,986,400
| – | – |
2017 Q1
2 quarters
|
|
23
DELISTED
ODP
ODP
| $45.4M | 0.82% |
1,000,000
-260,390
| -21% | -$12.9M |
2016 Q1
6 quarters
|
|
24
Chord Energy
CHRD
$7.61B
| $44.3M | 0.8% |
4,861,561
-6,286
| -0.1% | -$49.2K |
2013 Q3
16 quarters
|
|
|
25
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $43.1M | 0.77% |
2,450,000
-4,294,000
| -64% | -$96.6M |
2015 Q2
9 quarters
|
|
Similar funds
CL
John Paulson's Q3 2017 Portfolio in Review
As of Q3 2017, John Paulson held 115 positions worth $5.57B, down 25% from $7.4B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
John Paulson withdrew a net $1.38B in Q3 2017, closing 62 positions and reducing 20 holdings. Its most notable exit was American International, an estimated $259M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Communication Services and Miscellaneous.
Against the trend, John Paulson opened a new position in Calpine Corporation worth $24.8M.
- John Paulson's largest Q3 2017 buy was Calpine Corporation: 1,683,200 shares worth $24.8M.
- John Paulson added most to Altaba Inc in Q3 2017, an estimated $69M increase.
- John Paulson's biggest Q3 2017 reduction was NXP Semiconductors, cutting an estimated $133M.
- John Paulson fully exited American International in Q3 2017, selling an estimated $259M.
- John Paulson's ten largest holdings make up 64% of its $5.57B portfolio in Q3 2017.
- John Paulson opened 6 new positions and closed 62 in Q3 2017.
- John Paulson's portfolio value fell 25% quarter-over-quarter to $5.57B.
Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.